Blog Posts by Date: Nov 2017


Regulatory Challenges for Diagnostics in 2018: VP of Diagnostic Services Kyle Fetter to Speak at G2 Intelligence Lab Leadership Summit

  • November 30, 2017

Kyle Fetter, Vice President & General Manager of Diagnostic Services at XIFIN, will be speaking at this year's G2 Intelligence Lab Leadership Summit in Atlanta, GA on Friday, December 8th, 2017. The summit will focus on The Protecting Access to Medicare Act (PAMA); the effect this legislation has on clinical laboratory reimbursement, how...

Read



How to Prepare Your Lab for 2018: The Right Way

  • November 29, 2017

With the new year comes new regulations, and 2018 is no different. The changing year brings more compliance issues, fee schedules, and audit complications for the laboratory industry. XIFIN’s Vice President of Commercialization Strategies, Consulting, & Industry Affairs Rina Wolf will speak in a Pathology Webinar entitled "How to Prepare Your...

Read



2018 PAMA Pricing: Changes, Flaws & Impacts

  • November 27, 2017

The final 2018 clinical laboratory fee schedule (CLFS) is out, and it is evident that the argument that the Centers for Medicare & Medicaid Services (CMS) PAMA process was fundamentally flawed fell on deaf ears within CMS. Despite a groundswell urging delay, issued a final clinical lab fee schedule for 2018 that is, with a few exceptions, in...

Read



What’s the Best Way to Avoid Front-End Denials? Clean Claims.

  • November 20, 2017

Have you ever had a medical insurance claim denied? Most people have. The statistics vary based on the healthcare segment and the source, but typically the average claim denial rates range from 5% - 10%.  Centers for Medicare and Medicaid Services (CMS) reports their historical baseline for the number of Medicare Fee-for-Service claims...

Read



Understanding and Addressing Revenue Cycle Management Challenges in Hospital Outreach Laboratories

  • November 16, 2017

Hospital outreach laboratories provides a crucial healthcare service to local communities by enabling physicians and healthcare organizations to offer vital diagnostic services on an outpatient basis. However, economic and regulatory pressures are impacting revenue cycle management (RCM), reimbursement and financial viability for many outreach...

Read



Leverage Collective Appeals Intelligence to Improve Your Results

  • November 13, 2017

The appeals process is one place that many labs and diagnostics providers can improve automation, efficiency, and reimbursement. With XIFIN, labs gain an additional advantage through the collective intelligence gained from across the hundreds of thousands of appeals submitted each year by our clients. There are plenty of reasons that a claim can...

Read



XIFIN Executives Present at California Clinical Laboratory Association (CCLA) Conference

  • November 10, 2017

XIFIN Executive Chairman and CEO, Lâle White, and Vice President and General Manager for XIFIN Diagnostic Services, Kyle Fetter, presented at CCLA Conference 2017. Lâle's presentation showcased the bottom line for labs as it relates to the PAMA preliminary payment rates. In short, for about 75% of all codes on the Clinical Laboratory Fee Schedule...

Read



Silicon Review Names XIFIN One of the 50 Best Workplaces of the Year for 2017

  • November 7, 2017

The XIFIN team is proud to be named by Silicon Review one of the 50 best workplaces. In addition to being awarded this honor, Silicon Review published a profile on XIFIN as "a healthcare information technology company that leverages diagnostic information to improve the quality and economics of healthcare."The key messages in the profile cover:...

Read